Safety Shot Inc (NASDAQ: SHOT) stock jumped 0.66% on Friday to $1.53 against a previous-day closing price of $1.52. With 2.69 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.52 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $1.5400 whereas the lowest price it dropped to was $1.2400. The 52-week range on SHOT shows that it touched its highest point at $1.54 and its lowest point at $0.26 during that stretch. Beta for the stock currently stands at 0.13.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SHOT was up-trending over the past week, with a rise of 22.40%, but this was up by 50.00% over a month. Three-month performance surged to 451.10% while six-month performance rose 433.10%. The stock gained 84.59% in the past year, while it has gained 137.49% so far this year.
Float and Shares Shorts:
At present, 26.68 million SHOT shares are outstanding with a float of 20.15 million shares on hand for trading. On Aug 30, 2023, short shares totaled 2.45 million, which was 7.54% higher than short shares on Jul 30, 2023. In addition to Dr. Glynn Wilson Ph.D. as the firm’s Chief Scientific Officer & Chairman, Mr. Brian Scott John serves as its CEO & Exec. Director.
Through their ownership of 18.71% of SHOT’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 24.67% of SHOT, in contrast to 14.35% held by mutual funds. Shares owned by individuals account for 1.24%. As the largest shareholder in SHOT with 7.62% of the stake, The Glenview Trust Co. holds 2,091,556 shares worth 2,091,556. A second-largest stockholder of SHOT, Sabby Management LLC, holds 1,421,797 shares, controlling over 5.18% of the firm’s shares. The Vanguard Group, Inc. is the third largest shareholder in SHOT, holding 250,507 shares or 0.91% stake. With a 0.83% stake in SHOT, the Vanguard Extended Market Index Fu is the largest stakeholder. A total of 229,102 shares are owned by the mutual fund manager. The Fidelity Extended Market Index Fu, which owns about 0.19% of SHOT stock, is the second-largest Mutual Fund holder. It holds 51,735 shares valued at 56909.0. Fidelity Series Total Market Inde holds 0.10% of the stake in SHOT, owning 27,726 shares worth 30499.0.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, SHOT reported revenue of $3.00M and operating income of -$892.57k. The EBITDA in the recently reported quarter was -$870.33k and diluted EPS was -$0.07.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SHOT since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With SHOT analysts setting a high price target of $2.76 and a low target of $2.76, the average target price over the next 12 months is $2.76. Based on these targets, SHOT could surge 80.39% to reach the target high and rise by 80.39% to reach the target low. Reaching the average price target will result in a growth of 80.39% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded SHOT stock several times over the past three months with 16 Buys and 0 Sells. In these transactions, 18,500 shares were bought while 0 shares were sold. The number of buy transactions has increased to 19 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 140,500 while 0 shares were sold.